REFERENCES
1. Waldmann TA, Broder S, Krakauer R, MacDermott RP, Durm M, Goldman C et al. The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma. Fed Proc. 1976; 35: 2067-2072.
2. Siegal FP, Siegal M, Good RA. Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients.J Clin Invest. 1976; 58:109-22.
3. Strelkauskas AJ, Schauf V, Wilson BS, Chess L, Schlossman SF. Isolation and characterization of naturally occurring subclasses of human peripheral blood T cells with regulatory functions. J Immunol. 1978; 120: 1278-82.
4 Gupta S, Schwartz SA, Good RA. Subpopulations of human T lymphocytes. VII. Cellular basis of concanavalin A-induced T cell-mediated suppression of immunoglobulin production by B lymphocytes from normal humans. Cell Immunol. 1979; 44: 242-251.
5. Damle N, Gupta S. Autologous mixed lymphocyte reaction in man. V. Functionally and phenotypically distinct human T-cell subpopulations respond to non-T and activated T cells in AMLR. Scand J Immunol. 1982; 16: 59-68.
6. Damle NK, Gupta S. Heterogeneity of concanavalin A-induced suppressor T cells in man defined with monoclonal antibodies. Clin Exp Immunol. 1982; 48: 581-588.
7. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunological self tolerance maintained by activated T cells expressing IL-2 receptor alpha chain (CD25) Breakdown of a single mechanism of self tolerance causes various autoimmune diseases. J. Immunol. 1995; 155: 1151-1164
8. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FoxP3. Science 2003; 299: 1057-1061.
9. Fontenot JD, Gavin MA, Rudensky AY. FoxP3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003; 4: 330-336.
10. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H et al. TGF-beta 1 plays an important role in the mechanisms of CD4+CD25+ regulatory cell activity in both humans and mice. J. Immunol. 2004; 172: 834-842.
11. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001; 27: 20-21.
12. Endharti AT, Okuno Y, Shi Z, Misawa N, Toyokuni S, Ito M, et al. CD8+CD122+ regulatory T cells (Tregs) and CD4+ Tregs cooperatively prevent and cure CD4+ cell-induced colitis. J Immunol. 2011; 186: 41-52.
13. Lee YH, Ishida Y, Rifa’i M, Shi Z, Isobe K, Suzuki H. Essential role of CD8+CD122+ Treg in the recovery from experimental autoimmune encephalomyelitis. J. Immunol. 2008; 180: 825-832.
14. Ménager-Marcq I, Pomié C, Romagnoli P, van Meerwijk JP. CD8+CD28 regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology 2006; 131: 1775-1785.
15. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova J L, Buist N, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001; 27: 18-20.
16. Chen M-L, Yan B-S, Kozoriz D, Weiner HL. Novel CD8+ Treg suppress EAE by TGFβ- and IFN-γ-dependent mechanisms. Eur. J. Immunol. 2009; 39: 3423-46.
17. Brimnes J, Allez M, Dotan I, Shao L, Nakazawa A, Myer L. Defect in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J. Immunol. 2005; 174: 5814-5822.
18. Tennakoon DK, Mehta RS, Ortega SB, Bhoj V, Racke MK, Karandikar NJ. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis. J. Immunol. 2006; 176: 119-126.
19. Shi Z, Okuno Y, Rifa’I M, Endharti AT, Akane K, Isobe K-I, et al. Human CD8+CCR3+ T cells have same function as murine CD8+CD122+ Treg. Eur. J. Immunology 2009; 39: 2106-2119.
20. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, et al. Adenosine generation catabolized by CD39 and CD73 expressed on regulatory T cells mediate immune suppression. J. Exp. Med. 2004; 1257-1265
21. Chen M-L, Yan B-S, Kozoriz D, and Weiner HL. Novel CD8+ Treg suppress EAE by TGFβ- and IFN-γ-dependent mechanisms. Eur. J. Immunol. 2009; 39: 3423-3446.
22, Dai H, Wan N, Zhang S, Moore Y, Wan F, Dai Z. Cutting Edge: Programmed death-1 defines CD8+CD122+ T cells as regulatory versus memory T cells. J. Immunol. 2010; 124: 1130-1143.
23. Cosmi L, Liotta F, Lazzeri E, Francalanci M, Angeli R, Mazzinghi B et al. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 2003; 102: 4107-4114
24 Shou L, Schwartz SA, Good RA. Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med. 1976; 143: 1100-1110.
25. Schwartz SA, Choi YS, Shou L, Good RA. Modulatory effects on immunoglobulin synthesis and secretion by lymphocytes from immunodeficient patients. J. Clin. Invest. 1977; 59: 1176-1187
26. Schwartz SA, Shou L, Good RA, Choi YS. Suppression of immunoglobulin synthesis and secretion by peripheral blood lymphocytes by from normal donors. Proc. Natl. Acad. Sci. (USA) 1977; 74: 2099-2103.
27. Reinherz EL., Kung PC, Goldstein G, Schlossman SF. A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a hetero antiserum termed TH2. J. Immunol. 1980; 124: 1301-1307.
28. Chang CC, Ciubotariu R, Manavalan JS, Yuan J, Colovai AI, Piazza Fet al. Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002;3 : 237-243;
29. Long X, Cheng Q, Liang H, Zhao J, Wang J, Wang W et al.Memory CD4+ T cells are suppressed by CD8+ regulatory T cells in vitro and in vivo. Am J Transl Res 2017; 9: 63-78
30. Gupta S and Agrawal S. In vitro effect of CD8 Treg on B cell subsets. Int. Arch. Allergy Immunol. 2020;
31. Louis AG, Agrawal S, Gupta S. Analysis of subsets of B cells, Breg, CD4 Treg, and CD8 Treg in adult patients with selective IgM deficiency. Amer. J. Clin. Exp. Immunol. 2017; 5: 21-32.
32. Jarvis LB, Matyszak MK, Duggleby RC, Goodall JC, Hall FC, Gaston JS. Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function. Eur. J. Immunol. 2005; 35: 2896-2908.
33. Cai J, Lee J, Jankowska-Gan A, Derks R, Pool J, Mutis T, et al Minor H antigen HA-1-specific regulator and effector CD8+ T cells and HA-1 microchimerism in allograft tolerance. J. Exp. Med. 2004; 199: 1017-1023.